A study, published in The Annals of the Rheumatic Diseases, examined the impact of biological disease-modifying anti-rheumatic drugs and associated rheumatoid arthritis management guidelines on total hip and knee replacement incidence rates in Denmark.
Biologics
The American Academy of Orthopaedic Surgeons published a new position statement, "Use of Emerging Biologic Therapies."
Bone Biologics completed a preclinical study on its rhNELL-1 growth factor.
Fuse Medical is acquiring CPM Medical Consultants.
The Orthopaedic Research and Education Foundation and National Stem Cell Foundation gave Christopher L. Mendias, PhD, of New York City-based Hospital for Special Surgery, a research grant.
Advertisement
Denver Broncos defensive end Derek Wolfe will receive stem cell treatment for a neck injury, according to 247 Sports.
San Diego-based Sanford Burnham Prebys Medical Discovery Institute researchers studied what causes muscle stem cells to react differently to aging and injury, according to News Medical Life Sciences.
Israel's Technion Institute of Technology and Tel Aviv University researchers studied the impact of human stem cells on a rat's spinal cord injuries, Business Insider reports.
FDA clears market's 1st vertebral body replacement system with PEEK-OPTIMA HA Enhanced: 5 highlights
The FDA cleared the Omnia Medical VBR.
The global spine biologics market is anticipated to grow through 2023, according to a Transparency Market Research report.